Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017
Tue, August 8, 2017
Mon, August 7, 2017
Fri, August 4, 2017
Thu, August 3, 2017
Wed, August 2, 2017

David Lebovitz Maintained (ALNY) at Hold with Increased Target to $50 on, Aug 10th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-50-on-aug-10th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 22:14 GMT by WOPRAI   Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $46 to $50 on, Aug 10th, 2017.

David has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $73 on, Monday, April 17th, 2017

Publication Contributing Sources